The Oncology Pharmacist® features articles written by and for oncology pharmacists and specifically addresses the issues pharmacists and their colleagues face every day in clinical practice.
Featured Articles
-
Of MEDICINE and MIRACLES
The award-winning documentary Of Medicine and Miracles follows oncologist and Breakthrough Prize winner Dr Carl June of the University of Pennsylvania as he takes on the impossible: finding a cure for cancer. -
Incidence of Colorectal Cancer Rising in Young Adults
Colorectal cancer (CRC) is the second most common cause of cancer-related death in the United States and is the leading cause of death in men aged <50 years. -
Preliminary Results of a Real-World Study of the Safety and Efficacy of Surufatinib in BTC
Surufatinib, a small-molecule inhibitor targeting VEGFR1, VEGFR2, VEGFR3, FGFR1, and CSF-1R, has exhibited satisfactory clinical effectiveness and favorable safety and tolerability profiles when utilized as monotherapy in the treatment of patients with biliary tract cancer (BTC) in the second-line setting.
Top Trending Articles
In the Literature
Healthcare Disparities
Practical Issues for Pharmacists
Featured Video
Common Questions from NSCLC Patients and Their Caregivers
MAY SPOTLIGHT
-
Melanoma and Skin Cancer Awareness
In 2023, approximately 187,000 new cases of melanoma, the most dangerous of the 3 most common forms of skin cancer, occurred in the United States. Melanomas can be curable when caught and treated early, and research is ongoing to find treatments that offer hope to patients, including vaccines.
View Melanoma Articles View Skin Cancer Articles -
Melanoma
According to the American Cancer Society, approximately 106,110 individuals (62,260 men and 43,850 women) will be diagnosed with melanoma in the United States in 2021, and approximately 7180 individuals (4600 men and 2580 women) will die from the disease.
-
Melanoma
Approximately 3.4 million Americans will be diagnosed with skin cancer in 2022, making it the most common form of cancer in the United States. Included in this estimation are patients with basal-cell carcinoma and squamous-cell carcinoma, which are the most common types of skin cancer, as well as patients with melanoma, which accounts for approximately 1% of all skin cancers, but is responsible for a large majority of skin cancer–related deaths.
Upcoming Events
-
May 16-19, 2024
Loews Atlanta in Atlanta, Georgia -
October 16-18, 2024
New York Athletic Club, NYC